105 related articles for article (PubMed ID: 26022638)
1. Letter by Macrez et al. Regarding Article, "Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke".
Macrez R; Vivien D; Docagne F
Stroke; 2015 Jul; 46(7):e177. PubMed ID: 26022638
[No Abstract] [Full Text] [Related]
2. Response to Letter Regarding Article, "Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke".
Castillo-Gomez E; Ehrenreich H
Stroke; 2015 Jul; 46(7):e178. PubMed ID: 26022633
[No Abstract] [Full Text] [Related]
3. Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke.
Zerche M; Weissenborn K; Ott C; Dere E; Asif AR; Worthmann H; Hassouna I; Rentzsch K; Tryc AB; Dahm L; Steiner J; Binder L; Wiltfang J; Sirén AL; Stöcker W; Ehrenreich H
Stroke; 2015 May; 46(5):1180-6. PubMed ID: 25765725
[TBL] [Abstract][Full Text] [Related]
4. Stroke patients develop antibodies that react with components of N-methyl-D-aspartate receptor subunit 1 in proportion to lesion size.
Kalev-Zylinska ML; Symes W; Little KC; Sun P; Wen D; Qiao L; Young D; During MJ; Barber PA
Stroke; 2013 Aug; 44(8):2212-9. PubMed ID: 23723305
[TBL] [Abstract][Full Text] [Related]
5. Functional occurrence of the interaction of tissue plasminogen activator with the NR1 Subunit of N-methyl-D-aspartate receptors during stroke.
Macrez R; Bezin L; Le Mauff B; Ali C; Vivien D
Stroke; 2010 Dec; 41(12):2950-5. PubMed ID: 20966414
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against the NMDAR subunit NR1 are associated with neuropsychiatric outcome after ischemic stroke.
Deutsch NR; Worthmann H; Steixner-Kumar AA; Schuppner R; Grosse GM; Pan H; Gabriel MM; Hasse I; van Gemmeren T; Lichtinghagen R; Ehrenreich H; Weissenborn K
Brain Behav Immun; 2021 Aug; 96():73-79. PubMed ID: 34010714
[TBL] [Abstract][Full Text] [Related]
7. Detection of autoantibody against extracellular epitopes of N-methyl-D-aspartate receptor by cell-based assay.
Takano S; Takahashi Y; Kishi H; Taguchi Y; Takashima S; Tanaka K; Muraguchi A; Mori H
Neurosci Res; 2011 Nov; 71(3):294-302. PubMed ID: 21839784
[TBL] [Abstract][Full Text] [Related]
8. The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1.
Castillo-Gomez E; Kästner A; Steiner J; Schneider A; Hettling B; Poggi G; Ostehr K; Uhr M; Asif AR; Matzke M; Schmidt U; Pfander V; Hammer C; Schulz TF; Binder L; Stöcker W; Weber F; Ehrenreich H
Ann Neurol; 2016 Jan; 79(1):144-51. PubMed ID: 26505629
[TBL] [Abstract][Full Text] [Related]
9. N-methyl-d-aspartate receptor autoimmunity affects cognitive performance in herpes simplex encephalitis.
Westman G; Studahl M; Ahlm C; Eriksson BM; Persson B; Rönnelid J; Schliamser S; Aurelius E
Clin Microbiol Infect; 2016 Nov; 22(11):934-940. PubMed ID: 27497810
[TBL] [Abstract][Full Text] [Related]
10. All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class.
Castillo-Gómez E; Oliveira B; Tapken D; Bertrand S; Klein-Schmidt C; Pan H; Zafeiriou P; Steiner J; Jurek B; Trippe R; Prüss H; Zimmermann WH; Bertrand D; Ehrenreich H; Hollmann M
Mol Psychiatry; 2017 Dec; 22(12):1776-1784. PubMed ID: 27502473
[TBL] [Abstract][Full Text] [Related]
11. Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus.
Ogawa E; Nagai T; Sakuma Y; Arinuma Y; Hirohata S
Mod Rheumatol; 2016; 26(3):377-83. PubMed ID: 26429674
[TBL] [Abstract][Full Text] [Related]
12. Expression of N-methyl-D-aspartate receptor subunits in the bovine ovum: ova as a potential source of autoantigens causing anti-NMDAR encephalitis.
Tachibana N; Kinoshita M; Kametani F; Tanaka K; Une Y; Komatsu Y; Kobayashi Y; Ikeda S
Tohoku J Exp Med; 2015 Mar; 235(3):223-31. PubMed ID: 25786541
[TBL] [Abstract][Full Text] [Related]
13. [Autoantibodies to NMDA-type glutamate receptors in the blood of patients with acute ischemic and hemorrhagic stroke].
Skoromets AA; Dambinova SA; Iliukhina AIu; Sorokoumov VA
Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):53-8. PubMed ID: 11517478
[TBL] [Abstract][Full Text] [Related]
14. A case of anti-NMDAR (N-methyl-D-aspartate receptor) encephalitis: a rehabilitation perspective.
Tham SL; Kong KH
NeuroRehabilitation; 2012; 30(2):109-12. PubMed ID: 22430575
[TBL] [Abstract][Full Text] [Related]
15. [The level of autoantibodies to glutamate receptors in the blood serum of patients in the acute period of ischemic stroke].
Gusev EI; Skvortsova VI; Izykenova GA; Alekseev AA; Dambinova SA
Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(5):68-72. PubMed ID: 9012259
[TBL] [Abstract][Full Text] [Related]
16. [Autoantibodies against NMDA-receptors in the blood of patients with acute disorders of cerebral circulation].
Denisenko TV; Skuliabin DI; Gromov IA; Cherkas IuV; Iliukhina AIu; Dambinova SA
Vopr Med Khim; 1998; 44(6):584-90. PubMed ID: 10599146
[TBL] [Abstract][Full Text] [Related]
17. Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia.
Masdeu JC; González-Pinto A; Matute C; Ruiz De Azúa S; Palomino A; De Leon J; Berman KF; Dalmau J
Am J Psychiatry; 2012 Oct; 169(10):1120-1. PubMed ID: 23032395
[No Abstract] [Full Text] [Related]
18. Evaluation of titers of antibodies against peptides of subunits NR1 and NR2B of glutamate receptor by enzyme-linked immunosorbent assay in psychiatric patients with anti-thyroid antibodies.
Ikura T; Katsuse O; Chiba Y; Takahashi Y; Fujishiro H; Kamada A; Saito T; Hirayasu Y
Neurosci Lett; 2016 Aug; 628():201-6. PubMed ID: 27317996
[TBL] [Abstract][Full Text] [Related]
19. Antibodies preventing the interaction of tissue-type plasminogen activator with N-methyl-D-aspartate receptors reduce stroke damages and extend the therapeutic window of thrombolysis.
Macrez R; Obiang P; Gauberti M; Roussel B; Baron A; Parcq J; Cassé F; Hommet Y; Orset C; Agin V; Bezin L; Berrocoso TG; Petersen KU; Montaner J; Maubert E; Vivien D; Ali C
Stroke; 2011 Aug; 42(8):2315-22. PubMed ID: 21680906
[TBL] [Abstract][Full Text] [Related]
20. [Neuroprotective effects of glycine in the acute period of ischemic stroke].
Gusev EI; Skvortsova VI; Komissarova IA; Dambinova SA; Raevskiĭ KS; Alekseev AA; Bashkatova VG; Kovalenko AV; Kudrin VS; Iakovleva EV
Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(2):12-20. PubMed ID: 10081129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]